The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes

Erika Stefàno, Federica De Castro, Asjad Ali, Michele Benedetti, Francesco Paolo Fanizzi

Open source

DOI
10.3390/molecules30183828
Published
2025-09-21
Container
Molecules
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/molecules30183828,
  title = {The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes},
  author = {Erika Stefàno and Federica De Castro and Asjad Ali and Michele Benedetti and Francesco Paolo Fanizzi},
  year = {2025},
  journal = {Molecules},
  doi = {10.3390/molecules30183828},
  url = {https://doi.org/10.3390/molecules30183828}
}

RIS

TY  - JOUR
TI  - The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes
AU  - Erika Stefàno
AU  - Federica De Castro
AU  - Asjad Ali
AU  - Michele Benedetti
AU  - Francesco Paolo Fanizzi
PY  - 2025
JO  - Molecules
DO  - 10.3390/molecules30183828
UR  - https://doi.org/10.3390/molecules30183828
ER  - 

APA

Stefàno, E., Castro, F. D., Ali, A., Benedetti, M., & Fanizzi, F. P. (2025). The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes. Molecules. https://doi.org/10.3390/molecules30183828

Source records